Power
PrivateLast Round
Series A
Feb 21, 2024
Total Funding Raised
$19M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Power operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series A round in February 2024.
Power is a healthcare technology company that operates a clinical trial marketplace to connect qualified participants with researchers seeking pre-screened individuals for clinical studies.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Patient Engagement, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Marketplace Commission
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Power Comparables
Compare Power with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Trialbee | 84% | |
| Antidote Technologies | 82% | |
| Leal | 82% |
For institutional investors. Book with your work email.
Power Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 21, 2024 | ||||
| Seed | Aug 30, 2022 |
For institutional investors. Book with your work email.
Power Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AirAngels | Series A, Seed |
| Moment Ventures | Series A |
| Contrary Capital | Series A |
| South Park Commons | Seed |
| ARTIS Ventures | Series A, Seed |
| Kin Ventures | Series A |
| Common Metal | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 35% MoM, reaching 945.8K.
- Jan 1, 2025
Pharmaceutical customers pay per enrollment for services.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_awardSep 23, 2026
Power earns the 2024 and 2023 Society for Clinical Research Sites (SCRS) Eagle Award for advancing the clinical research profession through strong site partnerships.
- receives_awardSep 23, 2026
Power receives the 2024 Fierce Biotech CRO Award for "Innovative Approaches to Patient-Centric Research" in recognition of its innovative approaches to patient-centric research.
For institutional investors. Book with your work email.
Power Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Power's valuation, stock price, and market status.
Is Power a public or private company?
Power is a private company.
What is the current stock price of Power?
Power is a private company, so its shares have no public market price. Caplight tracks Power's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Power worth (valuation)?
Valuation information for Power is not publicly available.
Can I buy Power stock?
Power shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Power's last funding round?
Power's most recent funding round was Series A on February 21, 2024.
Who are the main investors in Power?
Key investors in Power include Contrary Capital, Kin Ventures, Kin Ventures, CRV, Footwork.
Will Power IPO soon?
No public IPO plans have been announced for Power.
How can I track Power secondary market activity?
Caplight tracks bids, offers, and trades in Power's shares on secondary markets.